<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We measured the concentrations of total (conjugated and unconjugated) <z:chebi fb="0" ids="25375">monoamines</z:chebi> (<z:chebi fb="40" ids="18243">dopamine</z:chebi>, <z:mp ids='MP_0000273'>DA</z:mp>; <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi>, NE) and <z:chebi fb="3" ids="25375">monoamine</z:chebi> metabolites (homovanillic acid, HVA; 3-<z:chebi fb="8" ids="32772">methoxy</z:chebi>-4-hydroxyphenyleneglycol, MHPG; 5-hydroxyindoleacetic acid, 5-HIAA) in the cerebrospinal fluid (CSF), using HPLC-<z:mp ids='MP_0010412'>ECD</z:mp> in 11 patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) or senile <z:hpo ids='HP_0000726'>dementia</z:hpo> of the Alzheimer type (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>), 17 patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> of the <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger</z:e> type (VDBT), and 15 controls </plain></SENT>
<SENT sid="1" pm="."><plain>In AD/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>, there was a significant decrease in the <z:mp ids='MP_0000273'>DA</z:mp> concentration and a significant increase in the MHPG concentration </plain></SENT>
<SENT sid="2" pm="."><plain>The average NE concentration was not altered, but significantly increased with the progression of <z:hpo ids='HP_0001249'>intellectual disability</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>There were no significant changes in HVA and 5-HIAA concentrations </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with VDBT showed a significant increase in the <z:mp ids='MP_0000273'>DA</z:mp> concentration and a significant decrease in HVA and 5-HIAA concentrations </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mp ids='MP_0000273'>DA</z:mp> concentrations increased significantly with the progression of <z:hpo ids='HP_0000726'>dementia</z:hpo> and ventricular enlargement </plain></SENT>
<SENT sid="6" pm="."><plain>These results indicate that the noradrenergic and dopaminergic system in particular are altered in AD/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>, while the dopaminergic and serotonergic systems are mainly involved in VDBT </plain></SENT>
</text></document>